12:00 AM
 | 
Dec 11, 2000
 |  BC Week In Review  |  Company News  |  Deals

Regeneron, Shearwater Polymers Inc. deal

Shearwater will use its PEGylation technology to develop a PEGylated form of REGN's Axokine second generation ciliary neurotrophic factor (

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >